<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pone.0209993</article-id><article-id pub-id-type="publisher-id">PONE-D-18-17148</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Dengue Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Arboviruses</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Diseases of the Nervous System</subject><subj-group><subject>Encephalitis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Infectious Diseases of the Nervous System</subject><subj-group><subject>Encephalitis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Arboviral Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Brazil</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Nervous System</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Nervous System</subject><subj-group><subject>Cerebrospinal Fluid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Enterovirus Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Molecular characterization of viruses associated with encephalitis in S&#x000e3;o Paulo, Brazil</article-title><alt-title alt-title-type="running-head">Molecular characterization of a viral etiology of encephalitis</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9729-9154</contrib-id><name><surname>Ferreira</surname><given-names>Jerenice E.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ferreira</surname><given-names>Suzete C.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Almeida-Neto</surname><given-names>Cesar</given-names></name><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nishiya</surname><given-names>Anna S.</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Alencar</surname><given-names>Cecilia S.</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gouveia</surname><given-names>Gisele R.</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Caiaffa-Filho</surname><given-names>Helio</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Helio</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3798-9273</contrib-id><name><surname>de Macedo Santos</surname><given-names>Raimunda Telma</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Witkin</surname><given-names>Steven S.</given-names></name><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mendrone-Junior</surname><given-names>Alfredo</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sabino</surname><given-names>Ester C.</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>LIM / 46&#x02014;Laboratory of Medical Parasitology, Institute of Tropical Medicine&#x02014;IMT, University of S&#x000e3;o Paulo Medical School USP, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Pathology Center, Adolf Lutz Institute&#x02013;IAL, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Funda&#x000e7;&#x000e3;o Pr&#x000f3;-Sangue Hemocentro de S&#x000e3;o Paulo&#x02013;FPS/HSP, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Disciplina de Ci&#x000ea;ncias M&#x000e9;dicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Central Laboratory Division&#x02014;Hospital das Cl&#x000ed;nicas S&#x000e3;o Paulo&#x02013;DLC-HCSP</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Clinical Laboratory and LIM 03&#x02013;Department of Pathology, Clinical Hospital, University of S&#x000e3;o Paulo Medical School, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Faculty of Medicine, University of S&#x000e3;o Paulo&#x02013;FMUSP, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Lin</surname><given-names>Baochuan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Defense Threat Reduction Agency, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>jerenice.ferreira@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><issue>1</issue><elocation-id>e0209993</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Ferreira et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ferreira et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0209993.pdf"/><abstract><p>The objective of this study was to characterize the prevalence of viral encephalitis due to arbovirus infection of the Togaviridae and Flaviviridae families in S&#x000e3;o Paulo, Brazil. A total of 500 cerebrospinal fluid (CSF) samples collected between August 2012 and January 2013, from patients with symptoms of acute encephalitis were analyzed. Findings suggestive of viral encephalitis&#x02014;elevations in cell concentration, glucose and total protein&#x02014;were observed in 234 (46.8%) samples, designated as Group 1. The remaining 266 samples comprised Group 2. All samples were tested for Flaviviruses (dengue virus 1, 2, 3 and 4, yellow fever virus and West Nile virus), Alphavirus (NS5 region) and enterovirus by RT- PCR and for herpesviruses and enteroviruses using CLART<sup>-</sup>Entherpex. A presumptive viral etiological agent was detected in 26 samples (5.2%), 18 (8.0%) in Group 1 and 8 (3.0%) in Group 2. In Group 1 human herpesviruses were detected in 9 cases, enteroviruses in 7 cases, dengue viruses (DENV) in 2 CSFs and St. Louis encephalitis virus (SLEV) in one case. In Group 2 there were 3 CSFs positive for human herpesviruses, 2 for enteroviruses, 2 for DENV and 1 for SLEV. Detection of arboviruses, even though present in a minority of infected patients, identifies these viruses as a probable etiological agent of encephalitis. This is of special concern in regions where this class of viruses is endemic and has been linked to other recent epidemics.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Foundation for Research Support of the State of S&#x000e3;o Paulo for the Financial Assistance (FAPESP)</institution></funding-source><award-id>Process Number: 2011 / 52094-3</award-id><principal-award-recipient><name><surname>Sabino</surname><given-names>Ester C.</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by Foundation for Research Support of the State of S&#x000e3;o Paulo for the Financial Assistance (FAPESP) (Process Number: 2011 / 52094-3). Principal Investigator: Ester C. Sabino.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="3"/><page-count count="10"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are available from <ext-link ext-link-type="uri" xlink:href="https://figshare.com/articles/Tables_1_and_2_CSF_Groups_1_and_2_data_/7135886">https://figshare.com/articles/Tables_1_and_2_CSF_Groups_1_and_2_data_/7135886</ext-link>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are available from <ext-link ext-link-type="uri" xlink:href="https://figshare.com/articles/Tables_1_and_2_CSF_Groups_1_and_2_data_/7135886">https://figshare.com/articles/Tables_1_and_2_CSF_Groups_1_and_2_data_/7135886</ext-link>.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Encephalitis is associated with high morbidity and mortality, as well as with cognitive, behavioral and even symptomatic epilepsies [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>]. Approximately 60% of patients suffer from severe memory disorder, which presents as clinical dementia [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>]. In addition to the personal, family and social cost, if these patients survive, they rarely become productive again [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0209993.ref002" ref-type="bibr">2</xref>]. The incidence of encephalitis ranges from 1.5 to 8/100,000 inhabitants, being higher in children under one year of age [<xref rid="pone.0209993.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>].</p><p>Viruses known to cause encephalitis worldwide are herpesviruses, arboviruses and enteroviruses [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>]. Arboviruses are the leading cause of encephalitis worldwide [<xref rid="pone.0209993.ref002" ref-type="bibr">2</xref>]. In developed countries, herpes simplex virus type 1 (HSV-1) is the leading cause of sporadic encephalitis in adults, while Varicella zoster virus (VZV) is responsible for up to 22% of pediatric cases [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>].</p><p>Overall, Japanese encephalitis virus (JEV) is the most prevalent arbovirus associated with neurological disease based on total number of annual cases [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>].</p><p>In the West, the West Nile virus (WNV) is the most frequent agent of arbovirus encephalitis and can be found in parts of Europe, Russia, Africa, the Middle East, India, Indonesia and North America [<xref rid="pone.0209993.ref001" ref-type="bibr">1</xref>]. There are few studies evaluating the prevalence of encephalitis-related viruses in Brazil [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>]. Similar to other countries, the most frequent cause of viral encephalitis in Brazil appears to be HSV- 1, followed by arboviruses [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>]. Bastos et al., identified the presence of herpesviruses, enteroviruses and arboviruses in CSF samples from 165 patients suspected of central nervous system viral infection by gene amplification [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>].</p><p>Among arboviruses circulating in Brazil, members of the Togaviridae, Flaviviridae, Peribunyaviridae, Reoviridae and Rhabdoviridae families cause the highest number of infections and diseases in humans [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>]. Bussuquara virus (AROAV), Cacicapor&#x000e9; virus (CPCV), dengue virus (DENV) serotypes 1&#x02013;4, Rocio virus (ROCV), Iguape virus (IGUV), Ilh&#x000e9;us virus (ILHV), yellow fever virus (YFV) and Saint Louis encephalitis virus (SLEV) have also been reported at low frequency in Brazil [<xref rid="pone.0209993.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0209993.ref007" ref-type="bibr">7</xref>]. Chikungunya virus (CHIKV) was first reported in Central America in late 2013, and by the end of 2014 was present in most countries in South America [<xref rid="pone.0209993.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0209993.ref013" ref-type="bibr">13</xref>]. Zika virus (ZIKV) was first reported in Brazil in 2014, but clinical cases were only recognized in mid-2015 in the states of Bahia and Rio Grande do Norte, located in the Northeast of Brazil [<xref rid="pone.0209993.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0209993.ref013" ref-type="bibr">13</xref>].</p><p>In Brazil there exists an elevated risk for the emergence and/or spread of new arboviruses to humans [<xref rid="pone.0209993.ref014" ref-type="bibr">14</xref>]. This country has large urban centers with a high population density that are infested by mosquitoes of the genus <italic>Culex</italic> and <italic>Aedes</italic> that transmit arboviruses to man [<xref rid="pone.0209993.ref014" ref-type="bibr">14</xref>]. The prevalence and dispersion of arboviruses has rapidly increased globally in recent years coinciding with improvements in global transportation, adaptation of its arthropod vectors to urbanization, failure to contain increases in the mosquito population and deforestation [<xref rid="pone.0209993.ref014" ref-type="bibr">14</xref>]. These arthropods apparently rapidly adapt to enhanced exposure to humans and domestic animals [<xref rid="pone.0209993.ref014" ref-type="bibr">14</xref>].</p><p>The primary objective of this study was to assess the prevalence of sporadic, non-seasonal viral encephalitis associated with arbovirus infection of the Togaviridae and Flaviviridae families in patients in S&#x000e3;o Paulo, Brazil. A second objective was to ascertain the prevalence of herpesviruses and enteroviruses in these patients and to identify the distribution of cases by gender, age, locality and characteristics of the cerebrospinal fluid (CSF).</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Clinical study design and sample collection</title><p>A cross-sectional study was performed from August 2012 to January 2013. A total of 500 cerebrospinal fluid samples were collected at the Hospital das Cl&#x000ed;nicas of the University of S&#x000e3;o Paulo Medical School (HCFMUSP) from individuals (both genders and any age group) with clinical suspicion of acute encephalitis (at least two of the following symptoms: fever, altered level of consciousness, headache, focal neurological deficits and seizure). HCFMUSP is the largest public hospital complex in Latin America, and is a center of tertiary care. It comprises eight institutes and two auxiliary hospitals with more than two thousand and one hundred beds [<xref rid="pone.0209993.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0209993.ref016" ref-type="bibr">16</xref>]. The distribution of encephalitis cases were from the metropolitan region, coastal and inland regions of S&#x000e3;o Paulo state as well as from other states in Brazil (Acre, Amazonas, Bahia, Cear&#x000e1;, Maranh&#x000e3;o, Par&#x000e1; and Paran&#x000e1;). Suspicious patients were referred to the Special Analysis / Liquor Department of the Central Laboratory of HCFMUSP, where the aspiration of CSF was performed from the lumbar region of the spinal cord. Collected material was sent for biochemical, microbiological and cytological analysis. From each sample collected, 1 mL was set aside for molecular investigation of viral agents. Research on human subjects was conducted after Hospital das Cl&#x000ed;nicas&#x02014;University of S&#x000e3;o Paulo&#x02019;s Institutional Review Board (CAPPesq) approval, online registration #8874/12. All patients provided written informed consent prior to CSF collection. In the case of patients under 18 years old, written consent was obtained of their parents or legal representatives.</p><p>Patients were classified into two groups according to CSF cellularity, glucose and total protein concentration. Group 1 included patients with pleocytosis (cellularity &#x0003e;4 cells/mm3) comprised predominantly of lymphocytes, glucose &#x0003e;50 mg/dL and protein &#x0003e;10 mg/dL. When one or more of these parameters were absent, patients were designated as Group 2 [<xref rid="pone.0209993.ref017" ref-type="bibr">17</xref>].</p><p>Physical characteristics of CSF were performed by visual observation of color and appearance before and after centrifugation. CSF biochemistry was performed by an automated method using the Modular Analytics System (Roche&#x02014;Switzerland). The cytological analysis of CSF was performed by manually using a Fucks-Rosenthal camera for global counts of red blood cells, leukocytes and tissue cells. A differential leukocyte count was performed by CytospinTM (Cytospin TM 4 Cytocentrifuge&#x02014;Thermo Fisher Scientific&#x02014;Massachusetts, USA). The pellet fraction was affixed to slides and staining was performed using the Hemogram Slide Ink equipment (Vyttra Diagn&#x000f3;sticos&#x02014;S&#x000e3;o Paulo&#x02014;Brazil) and a Colorgram kit (Wright-Giemsa-Leishman).</p></sec><sec id="sec004"><title>Molecular detection</title><sec id="sec005"><title>Extraction of nucleic acids</title><p>Viral RNA in CSF was extracted with the Qiagen UltraSens kit (QIAmpUltraSens&#x02014;QiagenGmbH, Hilden, Germany) using an initial volume of 250 &#x003bc;l according to the manufacturer's protocol. Two &#x003bc;l of canine adenovirus (DNA- CAV Vanguard HTLP 5 / CV-L 86-4230-65) at a 1/100 dilution was added as an exogenous internal control.</p></sec><sec id="sec006"><title>D-RT-PCR</title><p>Amplification of viral RNA was performed using the Duplex Reverse Transcription-PCR (D-RT-PCR) for detection and Identification of Alphaviruses and Flaviviruses, as described previously [<xref rid="pone.0209993.ref018" ref-type="bibr">18</xref>].</p></sec><sec id="sec007"><title>Real Time PCR</title><p>The quantitative real-time PCR reactions were performed according to the protocols Callahan et al., for DENV serotypes 1, 3 and 4 [<xref rid="pone.0209993.ref019" ref-type="bibr">19</xref>]; Johnson et al., for DENV serotype 2 [<xref rid="pone.0209993.ref020" ref-type="bibr">20</xref>]; Mantel et al., for yellow fever virus- YFV [<xref rid="pone.0209993.ref021" ref-type="bibr">21</xref>]; and Briese et al., for WNV in the NS5 region [<xref rid="pone.0209993.ref022" ref-type="bibr">22</xref>].</p><p>Real&#x02013;time PCR for enteroviruses was performed according to a methodology described by Volle et al. [<xref rid="pone.0209993.ref023" ref-type="bibr">23</xref>]. The CLART<sup>-</sup>Entherpex (BioM&#x000e9;rieux&#x02014;Ivry-sur-Seine, France) kit was used to identify eight human herpesviruses: HSV-1, herpes simplex virus type 2 (HSV-2), VZV, cytomegalovirus (CMV), Epstein- Barr virus (EBV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7) and human herpesvirus 8 (HHV-8) and the three major enteroviruses, poliovirus (PV), echovirus (E) and coxsackievirus (CV). The methodology is based on the detection of the amplification by RT-PCR of a fragment located between 106&#x02013;328 pb, which is detected by a low density micro-matrix platform (Microarray).</p></sec><sec id="sec008"><title>Sequencing</title><p>Samples of CSF in which virus was detected by D-RT-PCR were submitted to sequencing analysis according to the method of Sanger. The sequencing reaction was performed using the kit ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction (Applied Biosystems, Life Technologies, Carlsbad, California, United States) according to the manufacturer's instructions. Sequencing was completed using the Genetic Analyzer ABI 3100 (Applied Biosystems, Life Technologies, Carlsbad, California, U.S).</p><p>The sequences were analyzed using the program Sequencher 3.0 Sequencing Software (Ann Arbor, Michigan, United States) and compared with the genomic database GenBank (National Center for Biotechnology Information&#x02014;NCBI- Bethesda, Maryland, U.S).</p></sec></sec><sec id="sec009"><title>Statistical analysis</title><p>The statistical analyses, chi-square test, were performed using Epi Info version 7.2 (Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States) and Excel from Office 2010 (Redmond, Washington, United States).</p></sec></sec><sec id="sec010"><title>Results and discussion</title><p>Among 500 patients with a clinical suspicion of encephalitis, 234 (46.8%) of their CSF samples were positive for an increased concentrations of cells, protein and glucose. These patients, whose CSF findings were suggestive of viral encephalitis, were designated as Group 1. The remaining 266 subjects comprised Group 2. Identification of a possible viral etiologic agent of encephalitis was accomplished in only 18 (8.0%) CSF samples from patients in Group 1 and 8 (3.0%) from those in Group 2. <xref rid="pone.0209993.t001" ref-type="table">Table 1</xref> summarizes the demographic characteristics of patients according to rates of virus detection. Gender was equally divided between male and female and the largest groups of patients were those over 50 years old. There were no differences in either category between those positive or negative for viruses or between Groups 1 and 2.</p><table-wrap id="pone.0209993.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0209993.t001</object-id><label>Table 1</label><caption><title>Gender and age of patients with suspected viral encephalitis.</title></caption><alternatives><graphic id="pone.0209993.t001g" xlink:href="pone.0209993.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Data</th><th align="center" colspan="4" rowspan="1">Group 1</th><th align="center" colspan="4" rowspan="1">Group 2</th></tr><tr><th align="left" rowspan="1" colspan="1">(Variables)</th><th align="center" rowspan="1" colspan="1">Positive cases</th><th align="center" rowspan="1" colspan="1">Negative cases</th><th align="center" rowspan="1" colspan="1">Total</th><th align="center" rowspan="2" colspan="1"><italic>p value</italic></th><th align="center" rowspan="1" colspan="1">Positive cases</th><th align="center" rowspan="1" colspan="1">Negative cases</th><th align="center" rowspan="1" colspan="1">Total</th><th align="center" rowspan="2" colspan="1"><italic>p value</italic></th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">N = 18 (8.0%)</th><th align="center" rowspan="1" colspan="1">N = 216 (92.0%)</th><th align="center" rowspan="1" colspan="1">N = 234 (100%)</th><th align="center" rowspan="1" colspan="1">N = 8<break/>(3.0%)</th><th align="center" rowspan="1" colspan="1">N = 258 (97.0%)</th><th align="center" rowspan="1" colspan="1">N = 266 (100%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Gender</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">11 (5.0%)<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="center" rowspan="1" colspan="1">92 (39.0%)</td><td align="center" rowspan="1" colspan="1">103 (44.0%)</td><td align="center" rowspan="2" colspan="1">0.128</td><td align="center" rowspan="1" colspan="1">04 (1.5%)</td><td align="center" rowspan="1" colspan="1">133 (50.0%)</td><td align="center" rowspan="1" colspan="1">137 (51.5%)</td><td align="center" rowspan="2" colspan="1">0.931</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">07 (3.0%)</td><td align="center" rowspan="1" colspan="1">124 (53.0%)</td><td align="center" rowspan="1" colspan="1">131 (56.0%)</td><td align="center" rowspan="1" colspan="1">04 (1.5%)</td><td align="center" rowspan="1" colspan="1">125 (47.0%)</td><td align="center" rowspan="1" colspan="1">129 (48.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">0&#x02013;14</td><td align="center" rowspan="1" colspan="1">06 (2.7%)</td><td align="center" rowspan="1" colspan="1">14 (5.9%)</td><td align="center" rowspan="1" colspan="1">20 (8.6%)</td><td align="center" rowspan="4" colspan="1">0.000704</td><td align="center" rowspan="1" colspan="1">01 (0.4%)</td><td align="center" rowspan="1" colspan="1">19 (7.1%)</td><td align="center" rowspan="1" colspan="1">20 (7.5%)</td><td align="center" rowspan="4" colspan="1">0.926</td></tr><tr><td align="left" rowspan="1" colspan="1">15&#x02013;29</td><td align="center" rowspan="1" colspan="1">01 (0.5%)</td><td align="center" rowspan="1" colspan="1">33 (14.0%)</td><td align="center" rowspan="1" colspan="1">34 (14.5%)</td><td align="center" rowspan="1" colspan="1">02 (0.75%)</td><td align="center" rowspan="1" colspan="1">53 (19.9%)</td><td align="center" rowspan="1" colspan="1">55 (20.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">30&#x02013;49</td><td align="center" rowspan="1" colspan="1">03 (1.3%)</td><td align="center" rowspan="1" colspan="1">79 (33.7%)</td><td align="center" rowspan="1" colspan="1">82 (35.0%)</td><td align="center" rowspan="1" colspan="1">02 (0.75%)</td><td align="center" rowspan="1" colspan="1">81 (30.5%)</td><td align="center" rowspan="1" colspan="1">83 (31.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 50</td><td align="center" rowspan="1" colspan="1">08 (3.5%)</td><td align="center" rowspan="1" colspan="1">90 (38.4%)</td><td align="center" rowspan="1" colspan="1">98 (41.9%)</td><td align="center" rowspan="1" colspan="1">03 (1.1%)</td><td align="center" rowspan="1" colspan="1">105 (39.5%)</td><td align="center" rowspan="1" colspan="1">108 (40.6%)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>*One patient had concomitant positive results for EV (enterovirus) and HHV-6. Chi-square test.</p></fn></table-wrap-foot></table-wrap><p><xref rid="pone.0209993.t002" ref-type="table">Table 2</xref> summarizes the viruses detected in both groups. In Group 1 members of the herpesvirus family predominated (9 cases) followed by enteroviruses (7 cases). Three arbovirus infections, two of DENV and one case of SLEV were also identified. In Group 2 an equal number of herpesvirus and arbovirus (2 DENV, 1 SLEV) infections were detected (3 cases each), followed by enteroviruses (2 cases).</p><table-wrap id="pone.0209993.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0209993.t002</object-id><label>Table 2</label><caption><title>Molecular etiology of positive cases of viral encephalitis.</title></caption><alternatives><graphic id="pone.0209993.t002g" xlink:href="pone.0209993.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Data</th><th align="center" colspan="2" rowspan="1">Arboviruses N (%)</th><th align="center" colspan="5" rowspan="1">Herpesvirus N (%)</th><th align="center" rowspan="1" colspan="1">Enterovirus</th><th align="center" rowspan="1" colspan="1">Unknown</th></tr><tr><th align="left" rowspan="1" colspan="1">(Variables)</th><th align="center" rowspan="1" colspan="1">DENV</th><th align="center" rowspan="1" colspan="1">SLEV</th><th align="center" rowspan="1" colspan="1">HSV-1</th><th align="center" rowspan="1" colspan="1">EBV</th><th align="center" rowspan="1" colspan="1">CMV</th><th align="center" rowspan="1" colspan="1">HHV-6</th><th align="center" rowspan="1" colspan="1">VZV</th><th align="center" rowspan="1" colspan="1">N (%)</th><th align="center" rowspan="1" colspan="1">etiology</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Group 1</td><td align="left" rowspan="2" colspan="1">2 (0.8%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">4 (1.7%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">3 (1.3%)<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="left" rowspan="2" colspan="1">0 (0.0%)</td><td align="left" rowspan="2" colspan="1">7 (3.0%)<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="left" rowspan="2" colspan="1">216 (92.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">(N = 234)</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 2</td><td align="left" rowspan="2" colspan="1">2 (0.8%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">0 (0.0%)</td><td align="left" rowspan="2" colspan="1">0 (0.0%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">1 (0.4%)</td><td align="left" rowspan="2" colspan="1">2 (0.8%)</td><td align="left" rowspan="2" colspan="1">258 (97.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">(N = 266)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>*One patient had concomitant infection with EV (enterovirus) and HHV-6 (Real Time PCR and CLART<sup>-</sup>Entherpex). DENV: dengue virus (D-RT-PCR and Real Time PCR); SLEV: Saint Louis encephalitis virus (D-RT-PCR); HSV-1: Herpes Simplex virus type 1 (CLART<sup>-</sup>Entherpex); EBV: Epstein-Barr virus (CLART<sup>-</sup>Entherpex); CMV: Cytomegalovirus (CLART<sup>-</sup>Entherpex); HHV-6: Human herpesvirus 6 (CLART<sup>-</sup>Entherpex); VZV: Varicella zoster virus (CLART<sup>-</sup>Entherpex) [<xref rid="pone.0209993.ref020" ref-type="bibr">20</xref>&#x02013;<xref rid="pone.0209993.ref025" ref-type="bibr">25</xref>].</p></fn></table-wrap-foot></table-wrap><p>The two positive SLEV CSFs were both from women, 32- and 40- years-old, living in metropolitan S&#x000e3;o Paulo. One presented with facial palsy while the other had an uneventful clinical course without any adverse sequelae. Both SLEV samples underwent nucleotide sequencing to confirm their identity. The fragment obtained for the initial analysis was 232 bp. The sample from the Group 1 patient was 98% similar, and for the Group 2 patient 95% identical to SLEV isolated from the BsAsARG-10 NS5 gene (Sequence ID: gb JQ003910.1).</p><p><xref rid="pone.0209993.t003" ref-type="table">Table 3</xref> shows the cellularity, biochemistry and physical characters of CSF among patients in Groups 1 and 2 who tested positive for virus. These variables could not distinguish between the different viruses identified in either group.</p><table-wrap id="pone.0209993.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0209993.t003</object-id><label>Table 3</label><caption><title>CSF data from patients in Groups 1 and 2 who tested positive for virus.</title></caption><alternatives><graphic id="pone.0209993.t003g" xlink:href="pone.0209993.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1">Enterovirus</th><th align="left" colspan="2" rowspan="1">Herpesvirus</th><th align="left" colspan="2" rowspan="1">SLEV</th><th align="left" colspan="2" rowspan="1">DENV</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Group 1</th><th align="left" rowspan="1" colspan="1">Group 2</th><th align="left" rowspan="1" colspan="1">Group 1</th><th align="left" rowspan="1" colspan="1">Group 2</th><th align="left" rowspan="1" colspan="1">Group 1</th><th align="left" rowspan="1" colspan="1">Group 2</th><th align="left" rowspan="1" colspan="1">Group 1</th><th align="left" rowspan="1" colspan="1">Group 2</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Cellularity</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lymphomononuclear</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 10%</td><td align="left" rowspan="1" colspan="1">7 (3.0%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">9 (3.8%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c;10%</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythrocytes</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">1&#x02013;99 cells/mm<sup>3</sup></td><td align="left" rowspan="1" colspan="1">7 (3.0%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">9 (3.8%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 100 cells/mm<sup>3</sup></td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Biochemistry</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Glucose</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 50 mg/dL</td><td align="left" rowspan="1" colspan="1">7 (3.0%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">9 (3.8%)</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c; 50 mg/dL</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 10 mg/dL</td><td align="left" rowspan="1" colspan="1">7 (3.0%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">9 (3.8%)</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c; 10 mg/dL</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical Characters</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Clear and Colorless</td><td align="left" rowspan="1" colspan="1">4 (1.7%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">7 (3.0%)</td><td align="left" rowspan="1" colspan="1">3 (1.1%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Clear and Xantochromic</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Slightly Hemorrhagic</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Slightly turbid or cloudy</td><td align="left" rowspan="1" colspan="1">2 (0.8%)</td><td align="left" rowspan="1" colspan="1">1 (0.4%)</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Turbid or cloudy</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>SLEV: Saint Louis encephalitis virus.</p></fn></table-wrap-foot></table-wrap><p>The prevalence of arbovirus-related encephalitis in subjects in our study was 2.4%, including 4 cases of DENV and 2 of SLEV. This occurrence is lower than what has been reported in other investigations [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>]. Conversely, the identification of herpesviruses and enteroviruses as the most frequent CSF isolates from our patients is consistent with prior studies [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0209993.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0209993.ref025" ref-type="bibr">25</xref>]. However, rates of detection and the specific herpesviruses that were present differed between our study and other investigations. Recent studies in New Orleans reported a 20.4% prevalence of HSV and a 5.1% prevalence of VZV in encephalitis patients [<xref rid="pone.0209993.ref025" ref-type="bibr">25</xref>]. In the present study HHV-6 and EBV were the most prevalent herpesviruses viruses detected. Divergent population characteristics between S&#x000e3;o Paulo and New Orleans as well as differences in socio-economic levels, seasonal weather variations and alterations in mosquito-related variables could account for these variations [<xref rid="pone.0209993.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0209993.ref026" ref-type="bibr">26</xref>].</p><p>In Brazil, three strains of SLEV have been isolated from the blood of patients who did not display neurological symptoms. Two patients from Par&#x000e1;, in the North of the country, presented with fever and jaundice, and one from S&#x000e3;o Paulo had clinical symptoms consistent with dengue fever [<xref rid="pone.0209993.ref027" ref-type="bibr">27</xref>&#x02013;<xref rid="pone.0209993.ref029" ref-type="bibr">29</xref>]. Non-human SLEV infections have also been found in southeastern Brazil, where the virus was isolated from wild birds, rodents and sentinel mice during a surveillance program of arbovirus activity carried out in the state of S&#x000e3;o Paulo from 1967 to 1969 [<xref rid="pone.0209993.ref027" ref-type="bibr">27</xref>&#x02013;<xref rid="pone.0209993.ref029" ref-type="bibr">29</xref>]. In a study performed in cities in the Brazilian Amazon (Bragan&#x000e7;a and Salvaterra / Par&#x000e1;, Macap&#x000e1; / Amap&#x000e1; and Rio Branco / Acre) and in Maracaju, Mato Grosso do Sul in the midwest of the country, immunity to SLEV was identified in horses. No SLEV-associated disease was apparent in these animals [<xref rid="pone.0209993.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0209993.ref030" ref-type="bibr">30</xref>]. However, in a study carried out in Minas Gerais, Brazil, SLEV was found in the brain of a horse with neurological symptoms and its identity was confirmed by molecular and serological analysis [<xref rid="pone.0209993.ref031" ref-type="bibr">31</xref>]. SLEV is also considered as a possible etiological agent in human cases of dengue-like illness in S&#x000e3;o Paulo [<xref rid="pone.0209993.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0209993.ref032" ref-type="bibr">32</xref>]. Recently, SLEV was detected by molecular techniques in four serum samples from patients with clinical suspicion of dengue and in two patients with suspected viral meningoencephalitis, all from the Municipality of S&#x000e3;o Jos&#x000e9; do Rio Preto, State of S&#x000e3;o Paulo [<xref rid="pone.0209993.ref033" ref-type="bibr">33</xref>]. In the study by Heinen et al., SLEV was detected in three patients co-infected with DENV serotype 4 in the cities of Cuiab&#x000e1; and V&#x000e1;rzea Grande, one of whom had triple co-infection with DENV subtype1 [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0209993.ref034" ref-type="bibr">34</xref>&#x02013;<xref rid="pone.0209993.ref037" ref-type="bibr">37</xref>]. The small number of identified SLEV infections in people in Brazil is likely due to the occurrence of asymptomatic infections as well as difficulty in the differential diagnosis of individual flaviviruses [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0209993.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0209993.ref032" ref-type="bibr">32</xref>]. However, these studies are suggestive of a wide distribution of SLEV in Brazil [<xref rid="pone.0209993.ref029" ref-type="bibr">29</xref>].</p><p>The arrival of the WNV has been expected in Brazil since its appearance in the United States in 2000 [<xref rid="pone.0209993.ref038" ref-type="bibr">38</xref>&#x02013;<xref rid="pone.0209993.ref043" ref-type="bibr">43</xref>]. Acknowledging the limits of detection, our data suggest that this virus is not yet a cause of encephalitis in S&#x000e3;o Paulo.</p><p>Epidemics of DENV and ZIKV have been recent occurrences in Brazil and they are considered to be the most important flaviviruses circulating in this country [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0209993.ref034" ref-type="bibr">34</xref>]. Consequently, laboratory diagnosis during epidemic periods is directed at detection of these viruses. This hinders the detection of other circulating flaviviruses, including SLEV, which may silently becoming widely dispersed in the Americas [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0209993.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0209993.ref036" ref-type="bibr">36</xref>]. Therefore, our results indicate the need for a wider spectrum of active surveillance of arboviruses during outbreaks of dengue [<xref rid="pone.0209993.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0209993.ref034" ref-type="bibr">34</xref>].</p><p>In the present study no presumptive viral agent was identified in 90% of suspected cases of encephalitis. Worldwide, &#x0003e;70% of cases of presumptive encephalitis cases are not associated with any known infectious agent. Limitations and sensitivity of diagnostic methods, timing of sample collection and storage conditions, viral load and evolution of the disease in infected individuals are factors that may decrease ability to detect etiologic agents [<xref rid="pone.0209993.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0209993.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pone.0209993.ref046" ref-type="bibr">46</xref>]. In addition, a non-infectious etiology, due to sterile inflammation, autoimmunity or environmental exposures, remains an additional possibility.</p><p>This outbreak of 500 presumed encephalitis cases within a six month period was not registered at the S&#x000e3;o Paulo State Health Department most likely due to underreporting. This absence of official notification increases the likelihood that public health officials will be under-prepared to initiate measures to reduce exposure to causative agents, including arboviruses [<xref rid="pone.0209993.ref027" ref-type="bibr">27</xref>].</p></sec><sec sec-type="conclusions" id="sec011"><title>Conclusions</title><p>Although we found only a low prevalence of arboviruses in this encephalitis population, there remains a need to employ molecular tests to identify this class of viruses in patients with encephalitis. This is critical in our opinion due to epidemics caused by related flaviviruses in Brazil. Continuous monitoring of arbovirus as a cause of encephalitis is essential for the adequate treatment of these patients as well as for emphasizing a need for the implementation of sanitary measures to reduce the population of their mosquito vectors. The detection of different viruses in the central nervous system of patients with meningitis or encephalitis highlights the importance of maintaining a diagnostic laboratory capable of identifying a variety of viruses with high sensitivity [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>]. Detection of the specific causative virus will improve clinical decision making and the choice of the most appropriate antiviral therapy [<xref rid="pone.0209993.ref005" ref-type="bibr">5</xref>].</p><p>&#x02003;</p></sec></body><back><ack><p>We thank the Foundation for Research Support of the State of S&#x000e3;o Paulo for financial assistance (Process 2011 / 52094&#x02013;3). The funders had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0209993.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Kennedy</surname><given-names>PGE</given-names></name>. <article-title>Viral encephalitis</article-title>. <source>J Neurol</source>. <year>2005</year>; <volume>252</volume>: <fpage>268</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-005-0770-7</pub-id>
<?supplied-pmid 15761675?><pub-id pub-id-type="pmid">15761675</pub-id></mixed-citation></ref><ref id="pone.0209993.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Silva</surname><given-names>MT</given-names></name>. <article-title>Viral encephalitis</article-title>. <source>Arq Neuro-Psiquiatr</source>. <year>2013</year>; <volume>71</volume>: <fpage>703</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Gendelman</surname><given-names>HE</given-names></name>, <name><surname>Persidsky</surname><given-names>Y</given-names></name>. <article-title>Infections of the nervous system</article-title>. <source>Lancet Neurol</source>. <year>2005</year>; <volume>4</volume>: <fpage>12</fpage>&#x02013;<lpage>3</lpage>. Gilden DH. Acute viral central nervous system diseases. ACP Medicine. 2008; 1&#x02013;13. <pub-id pub-id-type="doi">10.1016/S1474-4422(04)00951-2</pub-id>
<?supplied-pmid 15620853?><pub-id pub-id-type="pmid">15620853</pub-id></mixed-citation></ref><ref id="pone.0209993.ref004"><label>4</label><mixed-citation publication-type="book"><name><surname>Vasconcelos</surname><given-names>PFC</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>APA</given-names></name>, <name><surname>Pinheiro</surname><given-names>FP</given-names></name>, <name><surname>Shope</surname><given-names>RE</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>JFS</given-names></name>, <name><surname>Rodrigues</surname><given-names>SG</given-names></name>, <etal>et al</etal>
<chapter-title>Arbovirusespathogenic for man in Brazil</chapter-title> In: <name><surname>Travassos da Rosa</surname><given-names>APA</given-names></name>, <name><surname>Vasconcelos</surname><given-names>PFC</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>JFS</given-names></name>, editors. <source>An overview of arbovirology in Brazil and neighbouring countries</source>. <publisher-name>CEJUP</publisher-name>
<year>1998</year>; <fpage>72</fpage>&#x02013;<lpage>99</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bastos</surname><given-names>MS</given-names></name>, <name><surname>Lessa</surname><given-names>N</given-names></name>, <name><surname>Naveca</surname><given-names>FG</given-names></name>, <name><surname>Monte</surname><given-names>RL</given-names></name>, <name><surname>Braga</surname><given-names>WS</given-names></name>, <name><surname>Figueiredo</surname><given-names>LT</given-names></name>, <etal>et al</etal>
<article-title>Detection of Herpesvirus, Enterovirus, and Arbovirus infection in patients with suspected central nervous system viral infection in the Western Brazilian Amazon</article-title>. <source>J Med Virol</source>. <year>2014</year>; <volume>86</volume>: <fpage>1522</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.23953</pub-id>
<?supplied-pmid 24760682?><pub-id pub-id-type="pmid">24760682</pub-id></mixed-citation></ref><ref id="pone.0209993.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Figueiredo</surname><given-names>LTM</given-names></name>. <article-title>The Brazilian flaviviruses</article-title>. <source>Microbes Infect</source>. <year>2000</year>; <volume>2</volume>: <fpage>1643</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 11113383?><pub-id pub-id-type="pmid">11113383</pub-id></mixed-citation></ref><ref id="pone.0209993.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Figueiredo</surname><given-names>RMP</given-names></name>, <name><surname>Naveca</surname><given-names>FG</given-names></name>, <name><surname>Bastos</surname><given-names>MS</given-names></name>, <name><surname>Melo</surname><given-names>MN</given-names></name>, <name><surname>Viana</surname><given-names>SS</given-names></name>, <name><surname>Mour&#x000e3;o</surname><given-names>MPG</given-names></name>, <etal>et al</etal>
<article-title>Dengue VirusType 4</article-title>. <source>Emerg Infect Dis</source>. <year>2008</year>; <volume>14</volume>: <fpage>667</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1404.071185</pub-id>
<?supplied-pmid 18394292?><pub-id pub-id-type="pmid">18394292</pub-id></mixed-citation></ref><ref id="pone.0209993.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Campos</surname><given-names>GS</given-names></name>, <name><surname>Bandeira</surname><given-names>AC</given-names></name>, <name><surname>Sardi</surname><given-names>SI</given-names></name>. <article-title>Zika virus outbreak, Bahia, Brazil</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>; <volume>21</volume>: <fpage>5</fpage>.</mixed-citation></ref><ref id="pone.0209993.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Zanluca</surname><given-names>C</given-names></name>, <name><surname>Melo</surname><given-names>VCA</given-names></name>, <name><surname>Mosimann</surname><given-names>ALP</given-names></name>, <name><surname>Santos</surname><given-names>GIV</given-names></name>, <name><surname>Santos</surname><given-names>CND</given-names></name>, <name><surname>Luz</surname><given-names>K</given-names></name>. <article-title>The first report of autochtonous transmission of Zika virus in Brazil</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2015</year>; <volume>110</volume>: <fpage>569</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1590/0074-02760150192</pub-id>
<?supplied-pmid 26061233?><pub-id pub-id-type="pmid">26061233</pub-id></mixed-citation></ref><ref id="pone.0209993.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Vasconcelos</surname><given-names>PFC</given-names></name>. <article-title>Doen&#x000e7;a pelo v&#x000ed;rus zika: um novo problem emergente nas Am&#x000e9;ricas</article-title>. <source>Rev Pan Amaz Saude</source>. <year>2015</year>; <volume>6</volume>: <fpage>9</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Faria</surname><given-names>NR</given-names></name>, <name><surname>da Costa</surname><given-names>AC</given-names></name>, <name><surname>Louren&#x000e7;o</surname><given-names>J</given-names></name>, <name><surname>Loureiro</surname><given-names>P</given-names></name>, <name><surname>Lopes</surname><given-names>ME</given-names></name>, <name><surname>Ribeiro</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Genomic and epidemiological characterization of a dengue virus outbreak among blood donors in Brazil</article-title>. <source>Sci Rep</source>. <year>2017</year>; <volume>7</volume>: <fpage>15216</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-15152-8</pub-id>
<?supplied-pmid 29123142?><pub-id pub-id-type="pmid">29123142</pub-id></mixed-citation></ref><ref id="pone.0209993.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Linnen</surname><given-names>JM</given-names></name>, <name><surname>Vinelli</surname><given-names>E</given-names></name>, <name><surname>Sabino</surname><given-names>EC</given-names></name>, <name><surname>Tobler</surname><given-names>LH</given-names></name>, <name><surname>Hyland</surname><given-names>C</given-names></name>, <name><surname>Lee</surname><given-names>TH</given-names></name>, <etal>et al</etal>
<article-title>Dengue viremia in blood donnorsfrom Honduras, Brazil, and Australia</article-title>. <source>Transfusion</source>. <year>2008</year>; <volume>48</volume>: <fpage>1355</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/j.1537-2995.2008.01772.x</pub-id>
<?supplied-pmid 18503610?><pub-id pub-id-type="pmid">18503610</pub-id></mixed-citation></ref><ref id="pone.0209993.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Lima-Camara</surname><given-names>TN</given-names></name>. <article-title>Emerging arboviruses and public health challenges in Brazil</article-title>. <source>Rev Saude Publica</source>. <year>2016</year>; <volume>50</volume>: <fpage>36</fpage>.</mixed-citation></ref><ref id="pone.0209993.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>E</given-names></name>, <name><surname>Pettersson</surname><given-names>J</given-names></name>, <name><surname>Higgs</surname><given-names>S</given-names></name>, <name><surname>Charrel</surname><given-names>R</given-names></name>, <name><surname>Lamballerie</surname><given-names>X</given-names></name>. <article-title>Emerging arboviruses: Why today?</article-title>
<source>One Health</source>. <year>2017</year>; <volume>4</volume>: <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.onehlt.2017.06.001</pub-id>
<?supplied-pmid 28785601?><pub-id pub-id-type="pmid">28785601</pub-id></mixed-citation></ref><ref id="pone.0209993.ref015"><label>15</label><mixed-citation publication-type="other">Cerri GG. Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo. "Gest&#x000e3;o 2010&#x02013;2014". 2014 May 15 [cited 01 Sep 2016]. In: Hospital das Cl&#x000ed;nicas web site [Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.hc.fm.usp.br/site/Hospital-das-Clinicas-da-FMUSP/">http://www.hc.fm.usp.br/site/Hospital-das-Clinicas-da-FMUSP/</ext-link>.</mixed-citation></ref><ref id="pone.0209993.ref016"><label>16</label><mixed-citation publication-type="other">Collucci C. HC faz anivers&#x000e1;rio em meio a reformas que somam R$ 350 milh&#x000f5;es. 2014 Apr 13 [cited 01 Sep 2016]. In: Folha de S. Paulo web site [Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www1.folha.uol.com.br/cotidiano/2014/04/1440047-hc-faz-aniversario-em-meio-a-reformas-que-somam-r-350-milhoes.shtml/">http://www1.folha.uol.com.br/cotidiano/2014/04/1440047-hc-faz-aniversario-em-meio-a-reformas-que-somam-r-350-milhoes.shtml/</ext-link>.</mixed-citation></ref><ref id="pone.0209993.ref017"><label>17</label><mixed-citation publication-type="other">Diretrizes Assistenciais. Protocolo de Encefalite. Hospital Israelita Albert Einstein. 21 Jun 2012. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.saudedireta.com.br/docsupload/1340280617Protocolo_%20E%20ncefalite%20(1).pdf">http://www.saudedireta.com.br/docsupload/1340280617Protocolo_%20E%20ncefalite%20(1).pdf</ext-link> Cited 01 Sep 2016.</mixed-citation></ref><ref id="pone.0209993.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Bronzoni</surname><given-names>RVM</given-names></name>, <name><surname>Baleotti</surname><given-names>FG</given-names></name>, <name><surname>Nogueira</surname><given-names>RMR</given-names></name>, <name><surname>Nunes</surname><given-names>M</given-names></name>, <name><surname>Figueiredo</surname><given-names>LTM</given-names></name>. <article-title>Duplex reverse transcription-PCR followed by nested PCR assays for detection of Brazilian Alphaviruses and Flaviviruses</article-title>. <source>J Clin Microbiol</source>. <year>2005</year>; <volume>43</volume>: <fpage>696</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.43.2.696-702.2005</pub-id>
<?supplied-pmid 15695666?><pub-id pub-id-type="pmid">15695666</pub-id></mixed-citation></ref><ref id="pone.0209993.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Callahan</surname><given-names>JD</given-names></name>, <name><surname>Wu</surname><given-names>SJ</given-names></name>, <name><surname>Dion-Schultz</surname><given-names>A</given-names></name>, <name><surname>Mangold</surname><given-names>BE</given-names></name>, <name><surname>Peruski</surname><given-names>LF</given-names></name>, <name><surname>Watts</surname><given-names>DM</given-names></name>, <etal>et al</etal>
<article-title>Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus</article-title>. <source>J Clin Microbiol</source>. <year>2001</year>; <volume>39</volume>: <fpage>4119</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.39.11.4119-4124.2001</pub-id>
<?supplied-pmid 11682539?><pub-id pub-id-type="pmid">11682539</pub-id></mixed-citation></ref><ref id="pone.0209993.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>BW</given-names></name>, <name><surname>Chambers</surname><given-names>TV</given-names></name>, <name><surname>Crabtree</surname><given-names>MB</given-names></name>, <name><surname>Guirakhoo</surname><given-names>F</given-names></name>, <name><surname>Monath</surname><given-names>TP</given-names></name>, <name><surname>Miller</surname><given-names>BR</given-names></name>. <article-title>Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction</article-title>. <source>Am J Trop Med Hyg</source>. <year>2004</year>; <volume>70</volume>: <fpage>89</fpage>&#x02013;<lpage>97</lpage>. <?supplied-pmid 14971704?><pub-id pub-id-type="pmid">14971704</pub-id></mixed-citation></ref><ref id="pone.0209993.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Mantel</surname><given-names>N</given-names></name>, <name><surname>Aguirre</surname><given-names>M</given-names></name>, <name><surname>Gulia</surname><given-names>S</given-names></name>, <name><surname>Girerd-Chambaz</surname><given-names>Y</given-names></name>, <name><surname>Colombani</surname><given-names>S</given-names></name>, <name><surname>Moste</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines</article-title>. <source>J Virol Methods</source>. <year>2008</year>; <volume>151</volume>: <fpage>40</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2008.03.026</pub-id>
<?supplied-pmid 18501437?><pub-id pub-id-type="pmid">18501437</pub-id></mixed-citation></ref><ref id="pone.0209993.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Briese</surname><given-names>T</given-names></name>, <name><surname>Glass</surname><given-names>WG</given-names></name>, <name><surname>Lipkin</surname><given-names>WI</given-names></name>. <article-title>Detection of West Nile virus sequences in cerebrospinal fluid</article-title>. <source>Lancet</source>. <year>2000</year>; <volume>355</volume>: <fpage>1614</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 10821368?><pub-id pub-id-type="pmid">10821368</pub-id></mixed-citation></ref><ref id="pone.0209993.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Volle</surname><given-names>R</given-names></name>, <name><surname>Nourrisson</surname><given-names>C</given-names></name>, <name><surname>Mirand</surname><given-names>A</given-names></name>, <name><surname>Regagnon</surname><given-names>C</given-names></name>, <name><surname>Chambon</surname><given-names>M</given-names></name>, <name><surname>Henquell</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Quantitative real-time RT-PCR assay for research studies on enterovirus infections in the central nervous system</article-title>. <source>J Virol Methods</source>. <year>2012</year>; <volume>185</volume>: <fpage>142</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2012.06.019</pub-id>
<?supplied-pmid 22766179?><pub-id pub-id-type="pmid">22766179</pub-id></mixed-citation></ref><ref id="pone.0209993.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Jaijakul</surname><given-names>S</given-names></name>, <name><surname>Salazar</surname><given-names>L</given-names></name>, <name><surname>Wootton</surname><given-names>SH</given-names></name>, <name><surname>Aguilera</surname><given-names>E</given-names></name>, <name><surname>Hasbun</surname><given-names>R</given-names></name>. <article-title>The clinical significance of neutrophilic pleocytosis in cerebrospinal fluid in patients with viral central nervous system infections</article-title>. <source>Int J Infect Dis</source>. <year>2017</year>; <volume>59</volume>: <fpage>77</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2017.04.010</pub-id>
<?supplied-pmid 28435023?><pub-id pub-id-type="pmid">28435023</pub-id></mixed-citation></ref><ref id="pone.0209993.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Kaewpoowat</surname><given-names>Q</given-names></name>, <name><surname>Salazar</surname><given-names>L</given-names></name>, <name><surname>Aguilera</surname><given-names>E</given-names></name>, <name><surname>Wootton</surname><given-names>SH</given-names></name>, <name><surname>Hasbun</surname><given-names>R</given-names></name>. <article-title>Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes</article-title>. <source>Infection</source>. <year>2016</year>; <volume>44</volume>: <fpage>337</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-015-0867-6</pub-id>
<?supplied-pmid 26680781?><pub-id pub-id-type="pmid">26680781</pub-id></mixed-citation></ref><ref id="pone.0209993.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Barcellos</surname><given-names>C</given-names></name>, <name><surname>Monteiro</surname><given-names>AMV</given-names></name>, <name><surname>Corval&#x000e1;n</surname><given-names>C</given-names></name>, <name><surname>Gurgel</surname><given-names>HC</given-names></name>, <name><surname>Carvalho</surname><given-names>MS</given-names></name>, <name><surname>Artaxo</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Mudan&#x000e7;as clim&#x000e1;ticas e ambientais e as doen&#x000e7;as infecciosas: cen&#x000e1;rios e incertezas para o Brasil</article-title>. <source>Epidemiol Serv Sa&#x000fa;de</source>. <year>2009</year>; <volume>18</volume>: <fpage>285</fpage>&#x02013;<lpage>304</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Santos</surname><given-names>CLS</given-names></name>, <name><surname>Sallum</surname><given-names>MAM</given-names></name>, <name><surname>Franco</surname><given-names>HM</given-names></name>, <name><surname>Oshiro</surname><given-names>FM</given-names></name>, <name><surname>Rocco</surname><given-names>IM</given-names></name>. <article-title>Genetic characterization of St Louis encephalitis virus isolated from human in S&#x000e3;o Paulo, Brasil</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2006</year>; <volume>101</volume>: <fpage>57</fpage>&#x02013;<lpage>63</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>De Souza Lopes</surname><given-names>O</given-names></name>, <name><surname>de Abreu Sachetta</surname><given-names>L</given-names></name>, <name><surname>Coimbra</surname><given-names>TL</given-names></name>, <name><surname>Pereira</surname><given-names>LE</given-names></name>. <article-title>Isolation of St. Louis encephalitis virus in south Brazil</article-title>. <source>Am J Trop Med Hyg</source>. <year>1979</year>; <volume>28</volume>: <fpage>583</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 453451?><pub-id pub-id-type="pmid">453451</pub-id></mixed-citation></ref><ref id="pone.0209993.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Rodrigues</surname><given-names>SG</given-names></name>, <name><surname>Oliva</surname><given-names>OP</given-names></name>, <name><surname>Ara&#x000fa;jo</surname><given-names>FAA</given-names></name>, <name><surname>Martins</surname><given-names>LC</given-names></name>, <name><surname>Chiang</surname><given-names>JO</given-names></name>, <name><surname>Henriques</surname><given-names>DF</given-names></name>
<etal>et al</etal>
<article-title>Epidemiologia do v&#x000ed;rus da encefalite de Saint Louis na Amaz&#x000f4;nia brasileira e no Estado de Mato Grosso do Sul, Brasil: elevada preval&#x000ea;ncia de anticorpos em equinos</article-title>. <source>Pan-Amaz Saude</source>. <year>2010</year>; <volume>1</volume>: <fpage>81</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref030"><label>30</label><mixed-citation publication-type="book"><name><surname>Travassos da Rosa</surname><given-names>APA</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>JFS</given-names></name>, <name><surname>Pinheiro</surname><given-names>FP</given-names></name>, <name><surname>Vasconcelos</surname><given-names>PFC</given-names></name>. <chapter-title>Arboviroses</chapter-title> In: <name><surname>Le&#x000e3;o</surname><given-names>RNQ</given-names></name>, coordenador. <source>Doen&#x000e7;as infecciosas e parasit&#x000e1;rias: enfoque amaz&#x000f4;nico</source>. <publisher-name>CEJUP</publisher-name>
<year>1997</year>; <fpage>208</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Rosa</surname><given-names>R</given-names></name>, <name><surname>Costa</surname><given-names>EA</given-names></name>, <name><surname>Marques</surname><given-names>RE</given-names></name>, <name><surname>Oliveira</surname><given-names>TS</given-names></name>, <name><surname>Furtini</surname><given-names>R</given-names></name>, <name><surname>Bomfim</surname><given-names>MR</given-names></name>, <etal>et al</etal>
<article-title>Isolation of saint louis encephalitis virus from a horse with neurological disease in Brazil</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>; <volume>7</volume>: <fpage>e2537</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002537</pub-id>
<?supplied-pmid 24278489?><pub-id pub-id-type="pmid">24278489</pub-id></mixed-citation></ref><ref id="pone.0209993.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Teixeira</surname><given-names>MG</given-names></name>, <name><surname>Barreto</surname><given-names>ML</given-names></name>, <name><surname>Guerra</surname><given-names>Z</given-names></name>. <article-title>Epidemiologia e medidas de preven&#x000e7;&#x000e3;o do Dengue</article-title>. <source>Inf Epidemiol Sus</source>. <year>1999</year>; <volume>8</volume>: <fpage>5</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Mondini</surname><given-names>A</given-names></name>, <name><surname>Cardeal</surname><given-names>ILS</given-names></name>, <name><surname>L&#x000e1;zaro</surname><given-names>E</given-names></name>, <name><surname>Nunes</surname><given-names>SH</given-names></name>, <name><surname>Moreira</surname><given-names>CC</given-names></name>, <name><surname>Rahal</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Saint Louis encephalitisvirus, Brazil</article-title>. <source>Emerg Infect Dis</source>. <year>2007</year>; <volume>13</volume>: <fpage>176</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid1301.060905</pub-id>
<?supplied-pmid 17370543?><pub-id pub-id-type="pmid">17370543</pub-id></mixed-citation></ref><ref id="pone.0209993.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Vasconcelos</surname><given-names>PFC</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>JFS</given-names></name>, <name><surname>Travassos da Rosa</surname><given-names>APA</given-names></name>, <name><surname>D&#x000e9;gallier</surname><given-names>N</given-names></name>, <name><surname>Pinheiro</surname><given-names>FP</given-names></name>, <name><surname>S&#x000e1; Filho</surname><given-names>GC</given-names></name>. <article-title>Epidemiologia das encefalites por arbov&#x000ed;rus na Amaz&#x000f4;nia brasileira</article-title>. <source>Inst Med Trop S&#x000e3;o Paulo</source>. <year>1991</year>; <volume>33</volume>: <fpage>465</fpage>&#x02013;<lpage>76</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Heinen</surname><given-names>LB</given-names></name>, <name><surname>Zuchi</surname><given-names>N</given-names></name>, <name><surname>Serra</surname><given-names>OP</given-names></name>, <name><surname>Cardoso</surname><given-names>BF</given-names></name>, <name><surname>Gondim</surname><given-names>BH</given-names></name>, <name><surname>Dos Santos</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Saint Louis encephalitis virus in Mato Grosso, central-western Brazil</article-title>. <source>Inst Med Trop S&#x000e3;o Paulo</source>. <year>2015</year>; <volume>57</volume>: <fpage>215</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Mondini</surname><given-names>A</given-names></name>, <name><surname>Bronzoni</surname><given-names>R</given-names></name>, <name><surname>Cardeal</surname><given-names>I</given-names></name>, <name><surname>Santos</surname><given-names>T</given-names></name>, <name><surname>L&#x000e1;zaro</surname><given-names>E</given-names></name>, <name><surname>Nunes</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Simultaneous infection by DENV-3 and SLEV in Brazil</article-title>. <source>J Clin Virol</source>. <year>2007</year>; <volume>40</volume>: <fpage>84</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2007.06.007</pub-id>
<?supplied-pmid 17658293?><pub-id pub-id-type="pmid">17658293</pub-id></mixed-citation></ref><ref id="pone.0209993.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Rocco</surname><given-names>IM</given-names></name>, <name><surname>Santos</surname><given-names>CLS</given-names></name>, <name><surname>Bisordi</surname><given-names>I</given-names></name>, <name><surname>Petrella</surname><given-names>SMCN</given-names></name>, <name><surname>Pereira</surname><given-names>LE</given-names></name>, <name><surname>Souza</surname><given-names>RP</given-names></name>, <etal>et al</etal>
<article-title>St. Louis encephalitis virus: first isolation from a human in S&#x000e3;o Paulo State, Brazil</article-title>. <source>Rev Inst Med Trop S&#x000e3;o Paulo</source>. <year>2005</year>; <volume>47</volume>: <fpage>281</fpage>&#x02013;<lpage>5</lpage>. doi: /S0036-46652005000500008 <?supplied-pmid 16302112?><pub-id pub-id-type="pmid">16302112</pub-id></mixed-citation></ref><ref id="pone.0209993.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Vieira</surname><given-names>MACS</given-names></name>, <name><surname>Aguiar</surname><given-names>AAX</given-names></name>, <name><surname>Borba</surname><given-names>AS</given-names></name>, <name><surname>Guimar&#x000e3;es</surname><given-names>HCL</given-names></name>, <name><surname>Eul&#x000e1;lio</surname><given-names>KD</given-names></name>, <name><surname>Albuquerque-Neto</surname><given-names>LL</given-names></name>. <article-title>West Nile Fever in Brazil: sporadic case, silent endemic disease or epidemic in its initial stages?</article-title>
<source>Rev. Inst. Med. Trop. S&#x000e3;o Paulo</source>. <year>2015</year>; <volume>57</volume>: <fpage>276</fpage>
<pub-id pub-id-type="doi">10.1590/S0036-46652015000300017</pub-id>
<?supplied-pmid 26200972?><pub-id pub-id-type="pmid">26200972</pub-id></mixed-citation></ref><ref id="pone.0209993.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Vieira</surname><given-names>MACS</given-names></name>, <name><surname>Romano</surname><given-names>APM</given-names></name>, <name><surname>Borba</surname><given-names>AS</given-names></name>, <name><surname>Silva</surname><given-names>EVP</given-names></name>, <name><surname>Chiang</surname><given-names>JO</given-names></name>, <name><surname>Eul&#x000e1;lio</surname><given-names>KD</given-names></name>
<etal>et al</etal>
<article-title>Case report: West Nile Virus Encephalitis: The first human case recorded in Brazil</article-title>. <source>Am I Trop Med Hyg</source>. <year>2015</year>; <volume>93</volume>: <fpage>377</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Fujita</surname><given-names>DM</given-names></name>, <name><surname>Salvador</surname><given-names>FS</given-names></name>, <name><surname>Nali</surname><given-names>LHDS</given-names></name>. <article-title>The silent spread of West Nile virus in Brazil: non-human positive case in a beach tourist destination-Espirito Santo</article-title>. <source>J Travel Med</source>. <year>2018</year>; <volume>25</volume>.</mixed-citation></ref><ref id="pone.0209993.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Whitley</surname><given-names>RJ</given-names></name>, <name><surname>Gnann</surname><given-names>JW</given-names></name>. <article-title>Viral encephalitis: familiar infections and emerging pathogens</article-title>. <source>The Lancet</source>. <year>2002</year>; <volume>359</volume>: <fpage>507</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Ferreira</surname><given-names>MLB</given-names></name>, <name><surname>Cavalcanti</surname><given-names>CG</given-names></name>, <name><surname>Coelho</surname><given-names>CA</given-names></name>, <name><surname>Mesquita</surname><given-names>SD</given-names></name>. <article-title>Manifesta&#x000e7;&#x000f5;es neurol&#x000f3;gicas de dengue: estudo de 41 casos</article-title>. <source>Arq. Neuro-Psiquiatr</source>. <year>2005</year>; <volume>63</volume>: <fpage>488</fpage>&#x02013;<lpage>93</lpage>.</mixed-citation></ref><ref id="pone.0209993.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Gubler</surname><given-names>DJ</given-names></name>. <article-title>The global emergence/resurgence of arboviral diseases as public health problems</article-title>. <source>Arch Med Res</source>. <year>2002</year>; <volume>33</volume>: <fpage>330</fpage>&#x02013;<lpage>42</lpage>. <?supplied-pmid 12234522?><pub-id pub-id-type="pmid">12234522</pub-id></mixed-citation></ref><ref id="pone.0209993.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Bale</surname><given-names>JF</given-names><suffix>Jr</suffix></name>. <article-title>Virus and Immune-Mediated Encephalitides: Epidemiology, Diagnosis, Treatment, and Prevention</article-title>. <source>Pediatric Neurology</source>. <year>2015</year>; <volume>53</volume>: <fpage>3</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2015.03.013</pub-id>
<?supplied-pmid 25957806?><pub-id pub-id-type="pmid">25957806</pub-id></mixed-citation></ref><ref id="pone.0209993.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Huppatz</surname><given-names>C</given-names></name>, <name><surname>Durrheim</surname><given-names>DN</given-names></name>, <name><surname>Levi</surname><given-names>C</given-names></name>, <name><surname>Dalton</surname><given-names>C</given-names></name>, <name><surname>Williams</surname><given-names>D</given-names></name>, <name><surname>Clements</surname><given-names>MS</given-names></name>, <etal>et al</etal>
<article-title>Etiology of Encephalitis in Australia, 1990&#x02013;2007</article-title>. <source>Emerging Infectious Diseases</source>. <year>2009</year>; <volume>15</volume>: <fpage>1359</fpage>&#x02013;<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.3201/eid1509.081540</pub-id>
<?supplied-pmid 19788802?><pub-id pub-id-type="pmid">19788802</pub-id></mixed-citation></ref><ref id="pone.0209993.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Le</surname><given-names>VT</given-names></name>, <name><surname>Phan</surname><given-names>TQ</given-names></name>, <name><surname>Do</surname><given-names>QH</given-names></name>, <name><surname>Nguyen</surname><given-names>BH</given-names></name>, <name><surname>Lam</surname><given-names>QB</given-names></name>, <name><surname>Bach</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Viral etiology of encephalitis in children in southern Vietnam: results of a one- year prospective descriptive study</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2010</year> 26; <volume>4</volume>: <fpage>e854</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0000854</pub-id>
<?supplied-pmid 21049060?><pub-id pub-id-type="pmid">21049060</pub-id></mixed-citation></ref></ref-list></back></article>